Facebook Pixel
The Money Café with Alan Kohler

The Ozempic Effect

On the Money Café this week, Alan Kohler and Stephen Mayne discuss Stephen's board tilt for NAB, the latest AGM news, Ozempic, and answer a number of listener questions on short selling, housing, managed fund fees, and much more.

See omnystudio.com/listener for privacy information.

The Money Café with Alan Kohler
Not playing